Skip to content

Gala Pharmaceutical Inc.

CIK 0001513403

← back to feed
Revenue (TTM)
$4.68K
Q2 Jul 2019
Net Income (TTM)
−$3.8M
+6.2% YoY Q2 Jul 2019
EPS Diluted (TTM)
—
Q2 Jul 2019
Gross Margin
31.2%
Q2 Jul 2019
Operating Margin
-6,639.1%
Q2 Jul 2019
Net Margin
-81,185.4%
Q2 Jul 2019
Free Cash Flow (TTM)
−$221.61K
Q2 Jul 2019
Cash
$179.29K
Q2 Jul 2019
Total Debt
—
Q2 Jul 2019
Shares Outstanding
118.02M sh
Q2 Jul 2019

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings